Mike Trout Testifies on Skaggs’ Drug Use in Urgent Trial

UPDATE: In a gripping testimony, Los Angeles Angels outfielder Mike Trout revealed he never witnessed any signs of drug use from his late teammate Tyler Skaggs before the tragic overdose that claimed Skaggs’ life in 2019. The testimony took place on October 3, 2023, during a civil trial in Santa Ana, California, concerning the Angels’ alleged negligence in the events leading to Skaggs’ death.

Trout, a three-time American League MVP and recent 400-home run milestone hitter, expressed profound sadness over Skaggs’ passing, recounting their close friendship that began when they were roommates as rookies. He described Skaggs as “very funny, outgoing, fun to be around,” emphasizing the personal loss felt by the team.

The trial centers on accusations against the Angels’ communication director, Eric Kay, who was convicted in 2022 for providing Skaggs with a counterfeit oxycodone pill laced with fentanyl. Kay is currently serving a 22-year prison sentence. The lawsuit, filed by Skaggs’ widow Carli Skaggs and his parents, seeks $118 million for lost earnings and punitive damages, claiming the Angels failed to protect players from Kay, who they allege was addicted to drugs.

Trout’s testimony highlighted a troubling dynamic within the team. He noted that Kay exhibited erratic behavior, often appearing “wired and sweating.” Trout recounted a moment when he approached Kay, expressing concern and offering support, but stated he had no idea what Kay was using at the time.

The Angels’ defense argues that Skaggs was also drinking heavily and that his drug use occurred in private. They contend that Skaggs was responsible for his own actions leading up to his death in a Texas hotel room, where he was found to have a toxic mix of alcohol, fentanyl, and oxycodone in his system.

The emotional weight of the trial is palpable, as it not only revisits the circumstances of Skaggs’ death but also raises critical questions about player safety and the responsibilities of organizations in preventing substance abuse. The trial, expected to last several weeks, may also see testimony from other MLB players, including former Angels pitcher Wade Miley.

As the proceedings unfold, the baseball community is watching closely, grappling with the implications of this case for player welfare and organizational accountability. With a tragic loss at its core, the case serves as a stark reminder of the dangers of addiction and the need for robust support systems within professional sports.

Stay tuned for further updates as this urgent trial progresses.